Estimating Periodontitis Susceptibility Cases for Epidemiological Studies with Multiple Imputation. [PDF]
Zhang L +4 more
europepmc +1 more source
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi +12 more
wiley +1 more source
Application of the estimand framework for an emulated trial using reference based multiple imputation to investigate informative censoring. [PDF]
Atkinson A +4 more
europepmc +1 more source
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro +17 more
wiley +1 more source
RNAseqCovarImpute: a multiple imputation procedure that outperforms complete case and single imputation differential expression analysis. [PDF]
Baker BH +4 more
europepmc +1 more source
A comparison of strategies for selecting auxiliary variables for multiple imputation. [PDF]
Mainzer RM +5 more
europepmc +1 more source
Multiple imputation integrated to machine learning: predicting post-stroke recovery of ambulation after intensive inpatient rehabilitation. [PDF]
Finocchi A +11 more
europepmc +1 more source
Evaluating the median <i>p</i>-value method for assessing the statistical significance of tests when using multiple imputation. [PDF]
Austin PC, Eekhout I, van Buuren S.
europepmc +1 more source
Comparison of common multiple imputation approaches: An application of logistic regression with an interaction. [PDF]
Smith MJ +4 more
europepmc +1 more source
Multiple imputation of more than one environmental exposure with nondifferential measurement error. [PDF]
Yu Y, Little RJ, Perzanowski M, Chen Q.
europepmc +1 more source

